Last reviewed · How we verify
Larocaine (dimethocaine)
Larocaine (generic name: dimethocaine) is a dimethocaine drug. It is currently in unknown development.
Larocaine works by blocking the reuptake of certain neurotransmitters, such as norepinephrine, serotonin, and dopamine, in the brain.
Dimethocaine, also known as larocaine, is a compound with a stimulatory effect that resembles cocaine but is reportedly less potent. It is listed as a legal cocaine replacement in some countries and is addictive due to its stimulation of the reward pathway in the brain.
At a glance
| Generic name | dimethocaine |
|---|---|
| Drug class | dimethocaine |
| Therapeutic area | Neuroscience |
| Phase | unknown |
Mechanism of action
Imagine your brain is a city with many different streets and intersections. Neurotransmitters are like cars that carry messages between different parts of the city. Larocaine helps keep these cars on the streets longer, allowing them to deliver their messages more effectively.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Larocaine CI brief — competitive landscape report
- Larocaine updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Larocaine
What is Larocaine?
How does Larocaine work?
What is the generic name of Larocaine?
What drug class is Larocaine in?
What development phase is Larocaine in?
Related
- Drug class: All dimethocaine drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Neuroscience
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing